Analysis of growth potential and valuation metrics for large-cap stocks Regeneron Pharmaceuticals, ServiceNow, and Progressive, highlighting investment risks and opportunities in the U.S. insurance and tech sectors.

Prudential PLC stands out with strong revenue growth and market position in Asia and Africa's life insurance and asset management sectors. Analysts remain bullish despite high forward P/E ratio, underscoring investment potential.

Validea updates multiple U.S. stock ratings based on Peter Lynch's P/E/Growth investment strategy, highlighting valuation changes and growth potential across sectors including insurance, real estate, healthcare, and energy.

Validea's Contrarian Investor model upgrades AES Corp, Fairfax Financial, and Sunoco LP ratings, highlighting improved fundamental and valuation metrics relevant to insurance and energy sectors.

Explore key trends in the U.S. life insurance industry including Fed interest rate impacts, product innovation, and digital technology adoption shaping growth and investment strategies.

Explore key challenges impacting Selective Insurance, Radian Group, and Mercury General including declining revenues, profitability pressures, and market valuation insights for informed insurance investment decisions.

F&G Annuities & Life shares declined 15% in six months despite 19.7% premium growth and strong book value gains, presenting a valuation opportunity in insurance stocks.

UnitedHealth Group's stock price rises on stable Medicare Advantage ratings and 2025 earnings guidance despite regulatory scrutiny and mixed insider trading activity.

Jackson Financial reports strong Q2 2025 earnings with $168M GAAP profit and increased annuity sales. Strong capital position sustains market resilience amid cautious stock outlook.